Wooree BIO

우리바이오 · 082850

Consumer Staples Food & Beverage · KOSDAQ

Small-cap

Market cap US$55.7M (₩76.8B)

Overview

Wooree BIO makes health-supplement foods, products formulated with functional ingredients designed to support wellness beyond ordinary nutrition, along with flexible circuit boards, LED lighting components, and LED backlighting assemblies for televisions.

Its supplements are approved by Korea's Ministry of Food and Drug Safety and are distributed under its own consumer brands. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across five distinct business divisions rather than concentrating on a single product line.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$756.5M

▼ −15.6% YoY

Operating profit · FY2025

US$690.2K

▼ −93.7% YoY

Net income · FY2025

−US$7.4M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$915.9M(₩1.3T)	US$896.5M(₩1.2T)	US$756.5M(₩1T)
Operating profit	US$18.8M(₩26B)	US$11M(₩15.2B)	US$690.2K(₩952.5M)
Net income	US$13.7M(₩18.9B)	US$6M(₩8.2B)	−US$7.4M(−₩10.2B)

Revenue

FY2023US$915.9M
FY2024US$896.5M
FY2025US$756.5M

Operating profit

FY2023US$18.8M
FY2024US$11M
FY2025US$690.2K

Net income

FY2023US$13.7M
FY2024US$6M
FY2025−US$7.4M

Key ratios (FY2025)

ROE

-3.9%

Debt/Eq

191.5%

Op. margin

0.1%

Net margin

-1.0%

Rev. YoY

▼ −15.6%

Why it matters

Certain of its health-supplement products are made under individually recognised ingredient approvals, which grant the holder exclusive rights to use those specific functional ingredients in Korea.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?